EE200200467A - 8,8a-dihüdroindeno[1,2-d]tiasooli derivaadid, mille 2-asendis on sulfoonamido- või sulfonorühma sisaldav asendaja, nende valmistamismeetod ja kasutamine ravimitena - Google Patents

8,8a-dihüdroindeno[1,2-d]tiasooli derivaadid, mille 2-asendis on sulfoonamido- või sulfonorühma sisaldav asendaja, nende valmistamismeetod ja kasutamine ravimitena

Info

Publication number
EE200200467A
EE200200467A EEP200200467A EEP200200467A EE200200467A EE 200200467 A EE200200467 A EE 200200467A EE P200200467 A EEP200200467 A EE P200200467A EE P200200467 A EEP200200467 A EE P200200467A EE 200200467 A EE200200467 A EE 200200467A
Authority
EE
Estonia
Prior art keywords
preparation
dihydroindeno
sulfonamido
pharmaceuticals
thiazole derivatives
Prior art date
Application number
EEP200200467A
Other languages
English (en)
Inventor
Jaehne Gerhard
Lang Hans-Jochen
Gossel Matthias
Bickel Martin
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200200467A publication Critical patent/EE200200467A/et
Publication of EE04963B1 publication Critical patent/EE04963B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Indole Compounds (AREA)
EEP200200467A 2000-02-26 2001-02-13 8,8a-dihdroindeno[1,2-d]tiasooli derivaadid, mille 2-asendis on sulfoonamido- v?i sulfonorhma sisaldav asendaja, nende valmistamismeetod ja kasutamine ravimitena EE04963B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10009311 2000-02-26
PCT/EP2001/001553 WO2001062747A1 (de) 2000-02-26 2001-02-13 8,8a-dihydro-indeno[1,2-d]thiazol-derivate, die in 2-stellung einen substituenten mit einer sulfonamidstruktur oder sulfonstruktur tragen; verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
EE200200467A true EE200200467A (et) 2003-12-15
EE04963B1 EE04963B1 (et) 2008-02-15

Family

ID=7632679

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200467A EE04963B1 (et) 2000-02-26 2001-02-13 8,8a-dihdroindeno[1,2-d]tiasooli derivaadid, mille 2-asendis on sulfoonamido- v?i sulfonorhma sisaldav asendaja, nende valmistamismeetod ja kasutamine ravimitena

Country Status (29)

Country Link
US (2) US6352987B2 (et)
EP (1) EP1261593B1 (et)
JP (1) JP4950405B2 (et)
KR (1) KR100763214B1 (et)
CN (1) CN1173959C (et)
AT (1) ATE248155T1 (et)
AU (2) AU2001244136B2 (et)
BR (1) BR0108631A (et)
CA (1) CA2400704C (et)
CZ (1) CZ301253B6 (et)
DE (1) DE50100558D1 (et)
DK (1) DK1261593T3 (et)
EE (1) EE04963B1 (et)
ES (1) ES2206412T3 (et)
HK (1) HK1052515B (et)
HR (1) HRP20020687B1 (et)
HU (1) HU229137B1 (et)
IL (1) IL151460A (et)
MX (1) MXPA02007025A (et)
NO (1) NO323400B1 (et)
NZ (1) NZ520981A (et)
PL (1) PL202763B1 (et)
PT (1) PT1261593E (et)
RS (1) RS49933B (et)
RU (1) RU2263113C2 (et)
SI (1) SI1261593T1 (et)
SK (1) SK285571B6 (et)
WO (1) WO2001062747A1 (et)
ZA (1) ZA200206580B (et)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7261482B2 (en) * 2004-01-21 2007-08-28 Silverbrook Research Pty Ltd Photofinishing system with slitting mechanism
EP1734963A4 (en) 2004-04-02 2008-06-18 Merck & Co Inc METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2348857B1 (en) 2008-10-22 2016-02-24 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US8329914B2 (en) 2008-10-31 2012-12-11 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
JP2013520502A (ja) 2010-02-25 2013-06-06 メルク・シャープ・エンド・ドーム・コーポレイション 有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
SG192941A1 (en) 2011-02-25 2013-09-30 Merck Sharp & Dohme Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
DK2681236T3 (en) 2011-03-01 2018-04-16 Synergy Pharmaceuticals Inc PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS
RU2015106909A (ru) 2012-08-02 2016-09-27 Мерк Шарп И Доум Корп. Антидиабетические трициклические соединения
KR20150118158A (ko) 2013-02-22 2015-10-21 머크 샤프 앤드 돔 코포레이션 항당뇨병 비시클릭 화합물
WO2014139388A1 (en) 2013-03-14 2014-09-18 Merck Sharp & Dohme Corp. Novel indole derivatives useful as anti-diabetic agents
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
WO2015051496A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
US11072602B2 (en) 2016-12-06 2021-07-27 Merck Sharp & Dohme Corp. Antidiabetic heterocyclic compounds
EP3558298B1 (en) 2016-12-20 2026-03-11 Merck Sharp & Dohme LLC Antidiabetic spirochroman compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
CA1292226C (en) * 1986-01-16 1991-11-19 Terumi Hachiya Indenothiazole derivative and process for preparing the same
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19844547C2 (de) * 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908533A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
CZ2001170A3 (cs) * 1999-07-03 2001-06-13 Aventis Pharma Gmbh Polycyklické thiazolidin-2-ylidenaminy, způsob jejich přípravy a léčivo, které je obsahuje
CZ20011111A3 (cs) * 1999-09-16 2001-07-11 Aventis Pharma Deutschland Gmbh Deriváty indeno-, nafto- a benzocyklohepťadihydrothiazolu, jejich příprava a použití jako anorektická léčiva

Also Published As

Publication number Publication date
AU4413601A (en) 2001-09-03
CZ20022861A3 (cs) 2002-11-13
NO20023977L (no) 2002-10-18
DE50100558D1 (de) 2003-10-02
EP1261593B1 (de) 2003-08-27
US20020103231A1 (en) 2002-08-01
IL151460A (en) 2008-08-07
ATE248155T1 (de) 2003-09-15
PT1261593E (pt) 2004-01-30
YU56402A (sh) 2005-11-28
RS49933B (sr) 2008-09-29
HRP20020687A2 (en) 2004-12-31
SI1261593T1 (en) 2004-02-29
US20010039278A1 (en) 2001-11-08
CA2400704C (en) 2008-11-04
NO323400B1 (no) 2007-04-23
CN1406234A (zh) 2003-03-26
US6352987B2 (en) 2002-03-05
DK1261593T3 (da) 2003-12-01
EP1261593A1 (de) 2002-12-04
KR20020079897A (ko) 2002-10-19
HU229137B1 (en) 2013-08-28
CZ301253B6 (cs) 2009-12-23
RU2263113C2 (ru) 2005-10-27
CN1173959C (zh) 2004-11-03
NZ520981A (en) 2004-08-27
ZA200206580B (en) 2003-05-15
EE04963B1 (et) 2008-02-15
PL357195A1 (en) 2004-07-26
US6444669B1 (en) 2002-09-03
AU2001244136B2 (en) 2005-04-14
SK285571B6 (sk) 2007-04-05
HUP0300304A3 (en) 2004-10-28
RU2002125673A (ru) 2004-01-10
WO2001062747A1 (de) 2001-08-30
CA2400704A1 (en) 2001-08-30
NO20023977D0 (no) 2002-08-21
HK1052515A1 (en) 2003-09-19
HK1052515B (zh) 2005-04-22
PL202763B1 (pl) 2009-07-31
HUP0300304A2 (hu) 2003-06-28
HRP20020687B1 (hr) 2011-01-31
JP2003531117A (ja) 2003-10-21
ES2206412T3 (es) 2004-05-16
SK12252002A3 (sk) 2003-03-04
MXPA02007025A (es) 2003-03-27
KR100763214B1 (ko) 2007-10-08
BR0108631A (pt) 2002-12-03
JP4950405B2 (ja) 2012-06-13

Similar Documents

Publication Publication Date Title
EE200200467A (et) 8,8a-dihüdroindeno[1,2-d]tiasooli derivaadid, mille 2-asendis on sulfoonamido- või sulfonorühma sisaldav asendaja, nende valmistamismeetod ja kasutamine ravimitena
NO20023978L (no) 8,8A-dihydro-indeno(1,2-D)tiazolderivater, substituert i posisjon 8A, en fremgangsmåte for deres fremstilling og deresanvendelse som legemidler, for eksempel anoreksimidler
BR0312513A (pt) Derivados de glicosìdeo de tiofeno, processos para a produção dos mesmos, medicamentos que contêm esses compostos e uso dos mesmos
BR0317283A (pt) Derivados heterocìclicos de flúor-glicosìdeo, medicamentos contendo estes compostos e seu uso
BRPI0407387A (pt) Derivados de hexahidro-pirazino[1,2-a]pirimidin-4,7-diona substituìdos por nitrogênio, processos para a sua preparação e sua aplicação com medicamento
CY1111481T1 (el) Υποκατεστημενα αρυλοκυκλοπροπυλακεταμιδια ως ενεργοποιητες γλυκοκινασης
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
IT1311923B1 (it) Composti farmaceutici.
HRP20041030B1 (hr) Derivati benzoksazina kao regulatori 5-ht6 i njihova upotreba
NO20052908L (no) Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
BR0213990A (pt) Derivados de piperazina tendo atividade antagonìstica de sst1
EP1671957A4 (en) THIADIAZOLINDERIVATE
BRPI0210746B8 (pt) derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina e seu método de preparação
BR0008510A (pt) Sistemas policìclicos de 2-amino-tiazol, processo para a sua preparação e medicamento contendo estes compostos
BR0113581A (pt) Derivados de aril-piperazinas e seu uso como psicofármacos
BR0317693A (pt) Derivados de epotilona
PT1183247E (pt) Sistemas tiazole policiclicos e sua utilizacao como anorecticos
UY26347A1 (es) Derivados de bencimidazol sustituidos con arilsulfonamida, procedimiento para su preparación y su empleo como medicamentos.
EE200200465A (et) Asendatud 8,8a-dihüdro-3aH-indeno[1,2-d]tiasoolid, nende valmistamismeetod ja kasutamine ravimitena
UY26617A1 (es) Derivados de 2-fenilpiran-4-ona
UY26346A1 (es) Derivados de bencimidazol sustituidos, procedimiento para preparación y su empleo como medicamentos.
BR9915898A (pt) Compostos, composição farmacêutica, e, utilização de um composto
DOP2002000362A (es) Nuevas arilsulfonamidas como agentes antivirales.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20150213